Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
about
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse Model.Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.Risk factors associated with high linezolid trough plasma concentrations.Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight.
P2860
Q33439246-6C83A628-7DF2-43D3-9222-FE377263D205Q33440964-EE54A6DE-80A5-4DDC-8796-4189DAB6CAF9Q37203803-454161EF-BEDB-4396-8EE1-3A9905822F15Q38777085-FE769688-148F-4BB6-A398-8EFFBCA241E6Q38929509-2B8EFCE9-649A-4075-AD49-4EBC420B6FDAQ39278957-63C4268C-6F93-4931-A0A7-EEC490DBD822Q40121784-44BE7B61-5E21-4B74-B350-870563E1B165Q40577600-239D4760-9069-48D5-BDAB-2D31EC8D3165Q40683242-F33FEB49-5529-4F2F-AB23-7B4FDE6C198AQ42797201-D552048A-B3CD-4F5F-9276-7EAF1C99A24A
P2860
Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Population pharmacokinetic ana ...... tients with renal dysfunction.
@en
Population pharmacokinetic ana ...... tients with renal dysfunction.
@nl
type
label
Population pharmacokinetic ana ...... tients with renal dysfunction.
@en
Population pharmacokinetic ana ...... tients with renal dysfunction.
@nl
prefLabel
Population pharmacokinetic ana ...... tients with renal dysfunction.
@en
Population pharmacokinetic ana ...... tients with renal dysfunction.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetic ana ...... atients with renal dysfunction
@en
P2093
Akiko Mizoguchi
Eiji Yukawa
Hidetoshi Kamimura
Kana Matsumoto
Kunihiko Morita
Yoshiharu Karube
P2860
P304
P356
10.1002/JCPH.133
P577
2013-09-01T00:00:00Z